Jan/Feb 2026 • PharmaTimes Magazine • 4-5

Contents

Features

Examining the role for pharma and how the sector can help break taboos

Could GLP-1 obesity drugs break pharma’s safety infrastructure?

Can the problem of delayed hospital patient discharge be solved?

Ten exciting new pharmaceutical drugs emerging in 2026

Analysis

Oncology across the NHS – can this become pharma’s moment?

The next chapter for UK pharma – the latest investment fund matters

Advancing ADC strategies in rare and difficult-to-treat cancers

Why Bayesian methods are moving into the regulatory mainstream

SmartPeople

14.
The man machine
Data-driven, patient-first – using insights to transform cancer care

18.
Serious gAIns
Redefining the future of customer relationships in biopharma

28.
Happy talk…
Training confident spokespeople – a guide for health sector communicators

36.
Making moves
Rise of digital healthcare – shaping a new type of patient experience

0
Logo

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com
https://pharmatimes.com/
Privacy Policy
Terms of Service

Categories

Explore our inspiring content by topic

PharmaTimes
News
Features
Analysis
SmartPeople

Social Footprints

Follow us on our Social Media Channels

X
linkedin